India's Suven Pharma soars on Q3 profit surge
** Suven Pharmaceuticals SUVH.NS jumps 7.3% to 1,125.2
rupees; set for biggest one-day pct gain since June 27, 2024
** Q3 consol net profit surges 77% y/y, boosted by strong
demand in its contract manufacturing business; rev up 40%
** Stock set to snap four straight days of declines
** More than 2.6 mln shares traded, over 12x the 30-day avg
** SUVH gained 57% in 2024
(Reporting by Aleef Jahan in Bengaluru)
((aleefjahan.cs@thomsonreuters.com))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss